| . | Type of “Maps to” relationship, % (n) . | |||
|---|---|---|---|---|
| Domain . | One-to-one . | Many-to-one . | One-to-many . | Many-to-many . |
| Condition | 1.9% (54 671) | 10.3% (292 507) | <0.1% (38) | 3.2% (90 034) |
| Device | 6.1% (172 216) | 3.6% (101 774) | <0.1% (4) | <0.1% (10) |
| Drug | 18.1% (515 360) | 42.6% (1 208 579) | <0.1% (181) | 1.6% (44 780) |
| Measurement | 0.5% (14 502) | 0.4% (11 580) | 1.2% (33 655) | 1.2% (33 489) |
| Observation | 3% (86 014) | 2.4% (69458) | <0.1% (3) | 0.2% (4579) |
| Procedure | 1.1% (29 973) | 2.5% (70 974) | <0.1% (16) | 0.2% (5581) |
| . | Type of “Maps to” relationship, % (n) . | |||
|---|---|---|---|---|
| Domain . | One-to-one . | Many-to-one . | One-to-many . | Many-to-many . |
| Condition | 1.9% (54 671) | 10.3% (292 507) | <0.1% (38) | 3.2% (90 034) |
| Device | 6.1% (172 216) | 3.6% (101 774) | <0.1% (4) | <0.1% (10) |
| Drug | 18.1% (515 360) | 42.6% (1 208 579) | <0.1% (181) | 1.6% (44 780) |
| Measurement | 0.5% (14 502) | 0.4% (11 580) | 1.2% (33 655) | 1.2% (33 489) |
| Observation | 3% (86 014) | 2.4% (69458) | <0.1% (3) | 0.2% (4579) |
| Procedure | 1.1% (29 973) | 2.5% (70 974) | <0.1% (16) | 0.2% (5581) |
| . | Type of “Maps to” relationship, % (n) . | |||
|---|---|---|---|---|
| Domain . | One-to-one . | Many-to-one . | One-to-many . | Many-to-many . |
| Condition | 1.9% (54 671) | 10.3% (292 507) | <0.1% (38) | 3.2% (90 034) |
| Device | 6.1% (172 216) | 3.6% (101 774) | <0.1% (4) | <0.1% (10) |
| Drug | 18.1% (515 360) | 42.6% (1 208 579) | <0.1% (181) | 1.6% (44 780) |
| Measurement | 0.5% (14 502) | 0.4% (11 580) | 1.2% (33 655) | 1.2% (33 489) |
| Observation | 3% (86 014) | 2.4% (69458) | <0.1% (3) | 0.2% (4579) |
| Procedure | 1.1% (29 973) | 2.5% (70 974) | <0.1% (16) | 0.2% (5581) |
| . | Type of “Maps to” relationship, % (n) . | |||
|---|---|---|---|---|
| Domain . | One-to-one . | Many-to-one . | One-to-many . | Many-to-many . |
| Condition | 1.9% (54 671) | 10.3% (292 507) | <0.1% (38) | 3.2% (90 034) |
| Device | 6.1% (172 216) | 3.6% (101 774) | <0.1% (4) | <0.1% (10) |
| Drug | 18.1% (515 360) | 42.6% (1 208 579) | <0.1% (181) | 1.6% (44 780) |
| Measurement | 0.5% (14 502) | 0.4% (11 580) | 1.2% (33 655) | 1.2% (33 489) |
| Observation | 3% (86 014) | 2.4% (69458) | <0.1% (3) | 0.2% (4579) |
| Procedure | 1.1% (29 973) | 2.5% (70 974) | <0.1% (16) | 0.2% (5581) |
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
